KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Treasury Shares (2016 - 2025)

Novavax (NVAX) has 16 years of Treasury Shares data on record, last reported at $103.0 million in Q4 2025.

  • For Q4 2025, Treasury Shares rose 7.48% year-over-year to $103.0 million; the TTM value through Dec 2025 reached $103.0 million, up 7.48%, while the annual FY2025 figure was $103.0 million, 7.48% up from the prior year.
  • Treasury Shares reached $2.4 million in Q4 2025 per NVAX's latest filing, up from $2.3 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.4 million in Q4 2025 and bottomed at $408989.0 in Q1 2021.
  • Average Treasury Shares over 5 years is $1.2 million, with a median of $893320.0 recorded in 2023.
  • Peak YoY movement for Treasury Shares: surged 1689.42% in 2021, then increased 1.77% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $85.1 million in 2021, then rose by 6.53% to $90.7 million in 2022, then grew by 1.77% to $92.3 million in 2023, then grew by 3.89% to $95.9 million in 2024, then grew by 7.48% to $103.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $103.0 million in Q4 2025, $102.7 million in Q3 2025, and $102.5 million in Q2 2025.